| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/23/2009 | US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/23/2009 | US7550595 Bronchodilators for treating chronic obstructive pulmonary disease or asthma; long duration of action; e.g. biphenyl-2-ylcarbamic acid 1-(2-([4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino)ethylpiperidin-4-yl ester; dosage forms such as metered dose inhalers |
| 06/23/2009 | US7550593 Dissolving finasteride in a solvent, replacing the solvent partially or substantially completely with a non-solvent and thereafter isolating finasteride Form I; 5-alpha reductase inhibitor, for example in the treatment of acne vulgaris, seborrhea, female hirsutism, androgenic alopecia |
| 06/23/2009 | US7550590 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 06/23/2009 | US7550587 Photosensitizer and method for production thereof |
| 06/23/2009 | US7550584 Methods of purifying beta glucans |
| 06/23/2009 | US7550580 heat shock protein 27 inhibitors; RNA interference; nuclease resistance |
| 06/23/2009 | US7550511 amino alcohols; selective ribonucleic acid (RNA) binding agents; detecting the binding of small molecules to T-box antiterminator model mRNAs; screening for microbiocidal drug targets; use disinfecting; antiviral, anti-HIV; e.g. use of 1,2-dihydroxy-3-amino-4-phenylbutane |
| 06/23/2009 | US7550510 Reacting hexachloroacetone with solvent-suspended resin-bound triphenylphosphine, chlorinating retinoic acid to provide retinoyl chloride, then stirring in pyridine; chromatography; for induction of apoptosis in cancer cells |
| 06/23/2009 | US7550509 Carisoprodol articles and methods |
| 06/23/2009 | US7550508 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 06/23/2009 | US7550507 2-(alpha-hydroxypentyl) benzoate and its preparation and use |
| 06/23/2009 | US7550506 Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 06/23/2009 | US7550505 Such as N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-3-(naphthalen-1-ylsulfonyl)propanamide; acne, seborrhea, hirsutism, alopecia, hidradenitis suppurativa; prostate cancer |
| 06/23/2009 | US7550504 In particular, butyrates and formates of divalent metals, as well as their carboxylate-aminoate or carboxylate-methioninate hydroxy analog derivatives of divalent metals; use as trace metal supplements in animal feed; increasing bioavailability of metals, therefore reducing their emission to environment |
| 06/23/2009 | US7550503 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy |
| 06/23/2009 | US7550502 e.g. 5-[(R)-1-(4-tert-Butyl-phenyl)-5-oxo-pyrrolidin-2-ylmethoxy]-pentanoic acid; prostaglandin EP2 agonist; ocular hypotensive, antiinflammatory agent; glaucoma, inflammatory bowel disease and as presurgical adjuncts |
| 06/23/2009 | US7550501 Compounds and methods for treating toll-like receptor 2-related diseases and conditions |
| 06/23/2009 | US7550500 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 06/23/2009 | US7550499 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/23/2009 | US7550498 Antiinflammatory agents, analgesics; e.g. Dimethyl-(2-[2-(8-thia-1,2-diaza-dibenzo[e,h]azulene-1-yl)-ethoxy]-ethyl)-amine and chemical intermediates; treating TNF-related disorders such as rheumatoid arthritis |
| 06/23/2009 | US7550497 sulfonamidophosphonate-functional heteroaryl compounds that contain SO2-NH-P(O)(-OR)2 group; antiinflammatory and analgesics; e.g. N-[4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]phenylsulfonyl]phosphoramidic acid; injectable COX-2 inhibitors |
| 06/23/2009 | US7550496 Hypoxia-activated prodrugs of alkylating agents such as of cyclophosphamide, ifosfamide, melphalan, chlorambucil, thiotepa; protected with 2-nitroimidazolyl group; targeted cancer cells more effectively, side effect reduction |
| 06/23/2009 | US7550495 1-(4,4-difluorocyclohexylmethyl)-2-tert-butyl-5-ethylsulfonamido-1H-benzimidazole; pain, cancer, multiple sclerosis, Parkinson's disease, Huntington's chorea, Alzheimer's disease, anxiety disorders, gastrointestinal disorders and/or cardiovascular disorders; CB1 receptor agonists; side effect reduction |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550493 Halogenated benzamide derivatives |
| 06/23/2009 | US7550492 Cholecystokinin (CCK2) receptor modulators; e.g. 2-(Benzo[1,2,5]thiadiazole-4sulfonylamino)-4-fluoro-N-[1-(4-fluoro-phenyl)-ethyl]-N-methyl-benzamide; pancreatic adenocarcinoma, pain, eating disorders, gastro-esophageal reflux disease, ulcers, anxiety |
| 06/23/2009 | US7550491 Ionic liquids having [N(CF3)2]− anions |
| 06/23/2009 | US7550490 Cancer and psoriasis; e.g. N-(2-amino-4-fluorophenyl)-4-[N-(Pyridin-3-ylacryloyl)aminomethyl]benzamide |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550488 Treating a patient suffering from facial submandibular cellulitis by applying a topical agent comprising 5 wt. % vitamin B5 and 30 wt. % vitamin B6 in a carrier selected from dimethyl sulfoxide and soy lecithin in combination with orally administering an antibiotic |
| 06/23/2009 | US7550487 Factor Xa inhibitors; anticoagulants; thrombotic disorders; (3R,4R)-3-(4-Chloro-phenylcarbamoyl)-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid propyl ester for example |
| 06/23/2009 | US7550486 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
| 06/23/2009 | US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride |
| 06/23/2009 | US7550484 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine |
| 06/23/2009 | US7550483 High usability as medicaments; useful as an angiogenesis inhibitor or a c-Kit kinase inhibitor; prepared by dissolving a crystalline form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide methanesulfonate in an alcohol and water |
| 06/23/2009 | US7550482 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| 06/23/2009 | US7550481 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 06/23/2009 | US7550480 1,8-naphthyridin-2(1H)-ones; treating CSBP/p38 kinase mediated diseases; cytokine suppressive anti-inflammatory drugs |
| 06/23/2009 | US7550479 Modified Pictet-Spengler reaction and products prepared therefrom |
| 06/23/2009 | US7550478 Tyrosine kinase inhibitors |
| 06/23/2009 | US7550477 Anticancer agents; initiasting mitosis which causes tumor cell death |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550474 Anticoagulants; strokes; restenosis; antiinflamamtory agents |
| 06/23/2009 | US7550473 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/23/2009 | US7550472 Substituted pteridines for the treatment of inflammatory diseases |
| 06/23/2009 | US7550471 5-alkyl-7-aminotriazolopyrimidines, methods and intermediary product necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms |
| 06/23/2009 | US7550470 Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors |
| 06/23/2009 | US7550469 Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/23/2009 | US7550468 Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase |
| 06/23/2009 | US7550467 1-(3-chloro-4-fluorophenyl)-3-(7-acetamidotetralin-2-yl)-3-(3-(4-methylpiperazinyl)propyl)-urea for example |
| 06/23/2009 | US7550466 Alpha and/or β-adrenergic antagonists and agonists to treat pain |
| 06/23/2009 | US7550465 imidazo[1,5-a]pyrido[3,2-e]pyrazines; neurologic and psychiatric disorders, for example psychosis |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550463 Carbamoylpyridone derivatives having inhibitory activity against HIV integrase |
| 06/23/2009 | US7550462 3-(2,3-dihydro-1H-inden-2-yl)-1-[1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[1-methylpropyl]-2,5-piperazinedione and acid addition salts thereof; pre-term labour, dysmenorrhea, endometriosis and benign prostatic hyperplasia, sexual disorders, fertility in farm animals |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | US7550459 Neurodegenerative diseases, psychological disorders; e.g. 4-[3-(3a -Cyclopropylmethoxy-8-azabicyclo[3.2.1]oct-8-yl)-2-methylpropyl]-4H-benzo[1.4]oxazin-3-one |
| 06/23/2009 | US7550458 Tricycloundecane compounds useful as modulators of nuclear hormone receptor function |
| 06/23/2009 | US7550457 Therapy of vascular system diseases |
| 06/23/2009 | US7550455 8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition |
| 06/23/2009 | US7550454 Analogs of clozapine; use with other neuropsychiatric agents; depression, anxiety, bipolar disorder, psychoses secondary to Alzheimer's or Huntington's disease; e.g. 2,7-Dichloro-11-(piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine |
| 06/23/2009 | US7550453 Anticancer agents; colon cancer or hepatocellular carcinoma; analogs of bengamide where the caprolactam ring is changed and/or substituted e.g. N-(2-Methyl-3-oxo-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl)-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide |
| 06/23/2009 | US7550452 N-Cholesteryloxyethylammonium (or amine) salt derivatives; compatible to gene therapy due to stability and highly transporting effects; drug delivery |
| 06/23/2009 | US7550451 Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy |
| 06/23/2009 | US7550450 Prostate cancer treatment |
| 06/23/2009 | US7550449 4-(alkylcarbonyloxymethyl)-2-oxo-2-methoxy-1,2-oxaphospholane; anticancer, antimetastasis agents |
| 06/23/2009 | US7550448 Therapeutic compounds |
| 06/23/2009 | US7550447 Method for precipitating nucleic acid with visible carrier |
| 06/23/2009 | US7550446 Modified hydroxyethyl- or hydroxypropyl-substituted starch product for clinical use, which has a degree of branching of 8-10 mol %, a degree of substitution of up to 0.3, an average molecular weight of 10000- 450000; product is not derived from an amylopectin fraction |
| 06/23/2009 | US7550445 Inclusion complex in a beta-cyclodextrin, preferably, sulfobutyl ether beta-cyclodextrin, in the form of an injectable material; reducing irritation normally caused by aripiprazole at an intramuscular injection site; for treating schizophrenia |
| 06/23/2009 | US7550444 Coatings with heparin activity, some able to release a bioactive agent; coatings can be formed using biostable or biodegradable polymeric material and photoreactive groups; improving the quality of bioactive agent-containing coatings by performing pre-irradiation of biocompatible coatings |
| 06/23/2009 | US7550443 prosthesis, stent medical device has a multilayer with bioactive agent-releasing coatings having heparin activity; coatings are formed using biostable or biodegradable polymeric material and photoreactive groups; absorbs light at different wavelength, without hurting the bioactive agent |
| 06/23/2009 | US7550442 For therapy of subject infected with a retrovirus |
| 06/23/2009 | US7550441 Controlled release polymer nanoparticle containing bound nucleic acid ligand for targeting |
| 06/23/2009 | US7550440 aqueous emulsion for the treatment of rosacea skin disorders, acne, dermatitis; Glycerol, Isopropyl palmitate, Cetyl alcohol, Stearyl monostearate, Oleyl alcohol, Ceteareth-20; good cosmetic properties and long shelf-life with minimum of 2 years |
| 06/23/2009 | US7550432 Recombinant fusion proteins to growth hormone and serum albumin |
| 06/23/2009 | US7550424 aromatic and heterocyclic sulfonamides, to treat preneoplastic and/or neoplastic diseases by specifically inhibiting the carbonic anhydrase activity of the oncoprotein now known alternatively as the MN protein, the MN/CA IX isoenzyme |
| 06/23/2009 | US7550160 Composition for treating cancer cells and preparation method for the same |
| 06/23/2009 | US7550159 For treatment of cancer and autoimmune diseases; kits |
| 06/23/2009 | US7550157 Method for the preparation of polymeric micelle via phase separation of block copolymer |
| 06/23/2009 | US7550155 two excipients are: a block co-polymer (for example, a poloxamer ), and a polyethylene glycol (PEG); with this synergistic mixture it is possible to dissolve or suspend higher amounts of propofol and other lipophilic compounds while, at the same time, using smaller amounts of these excipients |
| 06/23/2009 | US7550153 Pantoprazole multiparticulate formulations |
| 06/23/2009 | US7550146 Mucin motif found on epithelial tumor cell surfaces; antibody induction; cancer treatment |
| 06/23/2009 | US7550145 Adjuvant compositions |
| 06/23/2009 | US7550140 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy |
| 06/23/2009 | US7550135 Composition for external application |
| 06/23/2009 | US7550134 fluorene moiety attached to polymer backbone such as derived from an octadecene-maleic anhydride copolymer through a neopentyl glycol tether; stabilizing dibenzoylmethane compounds in sunscreens; waterproofing surfaces |
| 06/23/2009 | US7550133 comprise respiratory drug condensation aerosol particles; selected from the group consisting of beta -adrenergics, methylxanthines, anticholinergics, corticosteroids, mediator-release inhibitors, anti-leukotriene drugs, asthma inhibitors etc |
| 06/23/2009 | US7549424 Method and apparatus for tissue treatment with laser and electromagnetic radiation |
| 06/23/2009 | CA2551963C Pharmaceutical compositions and treatment of arteriosclerosis with cs-866 |
| 06/23/2009 | CA2535920C Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 06/23/2009 | CA2522220C Cgrp receptor antagonists |
| 06/23/2009 | CA2521509C Fast dissolving orally consumable films containing pharmaceutically active agents |
| 06/23/2009 | CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2459483C Plaster for the treatment of dysfunctions and disorders of nail growth |
| 06/23/2009 | CA2453917C Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |